Our Team
Our team is dedicated to improving outcomes and decreasing the cost of healthcare for spine surgery and beyond.
Mike is the co-founder and serves as Chief Executive Officer and President of Carlsmed, he also serves as Chairman of the Board of Directors.
Mike has over two decades of experience successfully leading teams in introducing groundbreaking medical technologies. He possesses extensive operational expertise in both private and public companies, having contributed to the success of organizations such as NuVasive, Ellipse Technologies, Zimmer Biomet, Orchid Orthopedics, and X-Spine Systems.
Mike holds a Bachelor of Science degree in Mechanical Engineering from the University of Dayton.
Jodi is Chief of Staff and Vice President of Strategic Initiatives at Carlsmed.
Jodi has over 10 years’ experience leading strategic planning and business intelligence in both public and private organizations, most recently at NuVasive.
She is an alumna of California State University, where she earned her Master of Business Administration, and holds a Bachelor of Arts in Political Science from the University of Illinois.
Sharon serves as Chief Clinical Officer of Carlsmed.
Sharon’s extensive professional journey includes senior leadership roles in marketing and surgical affairs at prominent companies such as J&J and Stryker. She has also played crucial C-suite roles at successful startup ventures, namely Micropore Biosurgery, N-Spine, and Tissue Regeneration Systems, all of which achieved successful exits.
Sharon holds a Bachelor of Science degree in Medical Technology from Loyola University Maryland.
Niall is the co-founder and serves as Chief Intellectual Property Officer of Carlsmed and serves as Secretary on the Board of Directors.
As a seasoned professional in the spine industry, Niall brings valuable experience from technology leadership roles at well-established companies such as Alphatec Spine, Ellipse Technologies, NuVasive, and J&J DePuy Synthes Spine.
Niall earned a J.D. from Suffolk University and an M.S. and B.S. degree in Biomedical Engineering from Case Western Reserve University.
Shariq serves as Chief Technology Officer at Carlsmed.
Shariq has a strong track record of entrepreneurship and execution in technology and executive leadership roles at MedTech companies Intelliguard Solutions and Safety Syringes.
Shariq’s educational background includes an M.B.A. in Technology Management from National University, a B.S. in Computer Science and Engineering from the University of California San Diego, and another B.S. in Information Technology from National University.
Leo serves as the Chief Financial Officer at Carlsmed.
Leo has over two decades of experience in business and finance. He has garnered expertise in the surgical device, pharmaceutical, and oncology diagnostics sectors. His leadership journey includes significant roles at prominent companies such as Spectrum Pharmaceuticals, Endologix, and most recently, Tarsus Pharmaceuticals.
Leo earned a Juris Doctor Degree from Temple University’s Beasley School of Law and Bachelor of Science Degree in Accounting from Arcadia University. He is a Certified Public Accountant and member of the California State Bar.
Tim is the Senior Vice President Global Business Development at Carlsmed.
With a wealth of experience exceeding 25 years, Tim has demonstrated leadership and global market management expertise. His professional journey includes pivotal roles at successful startup companies, including Intuitive Surgical, Mazor Robotics, and Augmedics.
Tim holds a Bachelor of Arts degree in Business Administration with a focus on Operations Management from Western Illinois University.
Scott currently serves as Chief Commercial Officer.
Prior to joining Carlsmed, Scott served in sales, marketing and corporate leadership roles across a medical device career spanning over 30 years, including highly successful tenures with U.S. Surgical Corporation, Boston Scientific Corporation, and NuVasive.
Scott attended the University of Kentucky where he obtained a Bachelor of Business Administration degree with a focus in Marketing.
Board of Directors
Mike is the co-founder and serves as Chief Executive Officer and President of Carlsmed, he also serves as Chairman of the Board of Directors.
Mike has over two decades of experience successfully leading teams in introducing groundbreaking medical technologies. He possesses extensive operational expertise in both private and public companies, having contributed to the success of organizations such as NuVasive, Ellipse Technologies, Zimmer Biomet, Orchid Orthopedics, and X-Spine Systems.
Mike holds a Bachelor of Science degree in Mechanical Engineering from the University of Dayton.
Niall is the co-founder and serves as Chief Intellectual Property Officer of Carlsmed and Secretary on the Board of Directors.
As a seasoned professional in the spine industry, Niall brings valuable experience from technology leadership roles at well-established companies such as Alphatec Spine, Ellipse Technologies, NuVasive, and J&J DePuy Synthes Spine.
Niall earned a J.D. from Suffolk University and an M.S. and B.S. degree in Biomedical Engineering from Case Western Reserve University.
Jon is a General Partner at U.S. Venture Partners. He serves as a Board Member at Edgewise Therapeutics, Inari Medical, Silverback Therapeutics, Cleave Therapeutics, HealthJoy, Okami Medical, Omada Health, Nuvaira, Ribon Therapeutics, Route 92 Medical and Sparrow Pharmaceuticals. Jon previously served as a Board Member at eFFECTOR Therapeutics, Lutonix, Microvention, OncoMed Pharmaceuticals, Sequent Medical and Proteolix.
Prior to U.S. Venture Partners, he was an Assistant Professor of Neurology and Director of the Neurology-Neurosurgery Special Care Unit at Cornell Medical Center.
Jon earned an M.D. from the University of Florida College of Medicine, an M.B.A. from Columbia University, and an A.B. in Economics from Dartmouth College.
Robert is a General Partner and Head of Healthcare who leads venture and growth investments at B Capital in the sector. Robert and his team have led investments in Hotspot Therapeutics, Lively, Aetion, Oncomyx, and Triumvira OR. He currently serves as a Board Director or Board Observer at Hotspot Therapeutics, Lively, Aetion, Oncomyx, and Triumvira. Previously, he served as a Board Director or Observer at Impel NeuroPharma, Silk Road Medical, TigerConnect, Avalyn Pharma, Neocis, Telcare, VisitPay, IntersectENT, iRhythm, Omada, TalkSpace, and iCardiac.
Prior to his career in venture capital, Robert led Marketing and Business Development at Hansen Medical.
Robert earned an M.D. from Harvard University, an M.B.A. from Harvard Business School, an M.S. in Systems Engineering from the Massachusetts Institute of Technology, and an M.A. in International Relations from Kings College London.
Phil serves as Senior Advisor at US Venture Partners, following 20 years as a managing general partner of the firm. He previously served as a Board Member at Aerogen, Aptus Endosystems, CardioThoracic Systems, CardioVascular Imaging Systems, CoCensys, Compugen, Dotomi, FemRx, HeartFlow, La Jolla Pharmaceuticals, Penederm, 3Dfx Interactive, RelayHealth, SentreHEART, Simpirica Spine, Synarc, St. Francis Medical Technologies, The Immune Response Corporation, Vical, Xoma and Zoran.
Prior to US Venture Partners, Phil was the President and CEO of Oximetrix. He also served on the Board of Trustees of Cornell University and was the Chair of eCornell for nearly 20 years.
Phil earned an M.B.A. from Harvard Business School, an M.S. in Engineering Physics from George Washington University, and a B.M.E. from Cornell University.
Kevin is a Board Member at Intrinsic Therapeutics, Miach Orthopaedics, Razor Medical, FzioMed, Shoulder Innovations, and Moximed.
He previously served on the Board at Rotation Medical, Ceterix, and Pivot Medical. Kevin is the former CEO of St. Francis Medical Technologies, Moximed, as well as past Worldwide President of Johnson & Johnson’s DePuy Orthopedics.
Kevin earned a B.S. in Accounting from West Virginia University.
Kevin is currently a Board Member at Nevro (NVRO), and previously served as a Director of seven publicly traded companies, including Wright Medical Group (WMGI), GenMark Diagnostics (GNMK) and Zeltiq (ZLTQ).
Kevin is a former Senior Vice President and CFO of Advanced BioHealing and served as CFO of NuVasive. Prior to that, he was CFO and COO at ChromaVision Medical Systems (CVSN). Kevin also held several leadership positions at Albert Fisher Group PLC, including CFO and SVP Operations.
Kevin earned a B.S. in Accounting from Rochester Institute of Technology and completed the Executive Program at the UCLA Anderson School of Management.
Management
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Dolores, facilis vitae similique nihil, pariatur, delectus voluptatum ea sapiente incidunt tenetur non officia adipisci repellendus neque libero error facere voluptatibus explicabo?